5.17
price up icon0.98%   0.05
pre-market  プレマーケット:  5.00   -0.17   -3.29%
loading
前日終値:
$5.12
開ける:
$5.1
24時間の取引高:
1.03M
Relative Volume:
0.49
時価総額:
$808.51M
収益:
$181.41M
当期純損益:
$-59.56M
株価収益率:
-12.31
EPS:
-0.42
ネットキャッシュフロー:
$-38.83M
1週間 パフォーマンス:
-1.15%
1か月 パフォーマンス:
+10.94%
6か月 パフォーマンス:
+49.86%
1年 パフォーマンス:
+114.52%
1日の値動き範囲:
Value
$5.08
$5.22
1週間の範囲:
Value
$5.0092
$5.34
52週間の値動き範囲:
Value
$2.095
$6.07

Xeris Biopharma Holdings Inc Stock (XERS) Company Profile

Name
名前
Xeris Biopharma Holdings Inc
Name
セクター
Healthcare (1161)
Name
電話
844-445-5704
Name
住所
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
Name
職員
394
Name
Twitter
@XerisPharma
Name
次回の収益日
2024-12-08
Name
最新のSEC提出書
Name
XERS's Discussions on Twitter

XERS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
XERS
Xeris Biopharma Holdings Inc
5.17 819.99M 181.41M -59.56M -38.83M -0.42
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-11 ダウングレード Piper Sandler Overweight → Neutral
2024-03-28 開始されました Oppenheimer Outperform
2023-08-28 開始されました Craig Hallum Buy
2022-10-21 開始されました Jefferies Buy
2022-04-28 開始されました Craig Hallum Buy
2021-11-17 開始されました SVB Leerink Outperform
2021-10-29 開始されました H.C. Wainwright Buy
2021-04-07 再開されました RBC Capital Mkts Outperform
2020-02-18 開始されました Piper Sandler Overweight
2018-07-16 開始されました Jefferies Buy
2018-07-16 開始されました Leerink Partners Outperform
2018-07-16 開始されました RBC Capital Mkts Outperform
すべてを表示

Xeris Biopharma Holdings Inc (XERS) 最新ニュース

pulisher
Jul 24, 2025

What analysts say about Xeris Biopharma Holdings Inc. stockFree Trend-Following Techniques - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Will Xeris Biopharma Holdings Inc. stock split in the near futureFree Trading Strategy Suggestions - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Xeris Biopharma Holdings Inc. Stock Analysis and ForecastExplosive capital gains - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

Is Xeris Biopharma Holdings Inc. a good long term investmentFree Technical Analysis Support - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Xeris Biopharma Holdings Inc. stock performs during market volatilitySmall Risk Large Return Trades - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Xponance Inc. Invests $57,000 in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 21, 2025
pulisher
Jul 20, 2025

What drives Xeris Biopharma Holdings Inc. stock priceBreakout stock performance - Autocar Professional

Jul 20, 2025
pulisher
Jul 16, 2025

how xeris biopharma holdings inc. stock performs during market volatilityMarket Timing Advice - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

why xeris biopharma holdings inc. stock attracts strong analyst attentionMassive Upside Selection - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Brown Advisory Inc. Has $630,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 15, 2025
pulisher
Jul 15, 2025

Why Xeris Biopharma Holdings Inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Xeris Biopharma Holdings Inc. stock price move sharplyBreakout Momentum Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

A Piece Of The Puzzle Missing From Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) 25% Share Price Climb - simplywall.st

Jul 15, 2025
pulisher
Jul 14, 2025

Xeris Biopharma's 7% Spike: Unraveling the Mysterious Move - AInvest

Jul 14, 2025
pulisher
Jul 10, 2025

Wealth Enhancement Advisory Services LLC Has $172,000 Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Xeris Biopharma's 10% Spike: A Technical and Market Flow Deep Dive - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Xeris Biopharma (NASDAQ:XERS) versus Mangoceuticals (NASDAQ:MGRX) Head to Head Review - Defense World

Jul 08, 2025
pulisher
Jun 28, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 28, 2025
pulisher
Jun 20, 2025

Rhumbline Advisers Increases Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 20, 2025
pulisher
Jun 19, 2025

Wealth Enhancement Advisory Services LLC Raises Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Xeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term Investing - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Up 8.4% Following Insider Buying Activity - Defense World

Jun 18, 2025
pulisher
Jun 15, 2025

Pallas Capital Advisors LLC Acquires New Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 15, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Has $138,000 Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Leerink Partnrs Estimates Xeris Biopharma FY2025 Earnings - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Leerink Partnrs Forecasts Lower Earnings for Xeris Biopharma - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Down 5.5%Should You Sell? - MarketBeat

Jun 06, 2025
pulisher
Jun 05, 2025

Leerink Partners raises Xeris Pharmaceuticals stock price target By Investing.com - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Transcript : Xeris Biopharma Holdings, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 01 - MarketScreener

Jun 05, 2025
pulisher
Jun 04, 2025

Xeris at Jefferies Conference: Strategic Growth and Future Prospects By Investing.com - Investing.com Canada

Jun 04, 2025
pulisher
Jun 04, 2025

xeris biopharma holds annual meeting, elects directors By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

xeris biopharma holds annual meeting, elects directors - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Xeris Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Xeris Biopharma touts ambitious growth plan, promising hypothyroidism drug - Crain's Chicago Business

Jun 04, 2025
pulisher
Jun 04, 2025

Xeris at Jefferies Conference: Strategic Growth and Future Prospects - Investing.com

Jun 04, 2025

Xeris Biopharma Holdings Inc (XERS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):